Harbor Investment Advisory »

Crispr Therapeutics shares owned by Harbor Investment Advisory

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Harbor Investment Advisory from 13F filings

Historical chart of Harbor Investment Advisory investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Harbor Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Harbor Investment Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $421k 6.2k 68.16
2023-12-31 $386k 6.2k 62.60
2023-09-30 $301k 6.6k 45.39
2023-06-30 $372k 6.6k 56.14
2023-03-31 $325k 7.2k 45.23
2022-12-31 $320k 7.9k 40.65
2022-09-30 $727k 11k 65.35
2022-06-30 $688k 11k 60.76
2022-03-31 $714k 11k 62.77
2021-12-31 $1.2M 16k 75.78
2021-09-30 $1.8M 16k 111.92
2021-06-30 $2.7M 16k 161.89
2021-03-31 $2.0M 16k 121.85
2020-12-31 $2.4M 15k 153.11
2020-09-30 $1.2M 14k 83.61
2020-06-30 $1.0M 14k 73.50
2020-03-31 $437k 10k 42.41
2019-12-31 $579k 9.5k 60.95